FGLR:XETRA:XETRA-Fidelity Sustainable Research Enhanced Global Equity UCITS ETF USD Acc (EUR)

ETF | Others |

Last Closing

USD 8.484

Change

+0.04 (+0.41)%

Market Cap

USD 0.05B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

+0.56 (+1.23%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.76 (+0.77%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.32 (+1.34%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

+0.16 (+1.19%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

+0.09 (+1.59%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

+0.26 (+1.10%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

+0.12 (+0.93%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

-0.52 (-0.90%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

+0.08 (+0.79%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.20 (+0.16%)

USD 12.26B

ETFs Containing FGLR:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.79% 29% F 29% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.79% 34% F 33% F
Trailing 12 Months  
Capital Gain 5.13% 59% D- 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.13% 61% D- 60% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.63% 65% D 65% D
Dividend Return 9.63% 65% D 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.08% 55% F 64% D
Risk Adjusted Return 86.89% 77% C+ 80% B-
Market Capitalization 0.05B 26% F 21% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.